Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices – Market Insights – Latin America (Supplemental)

The Latin American PV device market will see increasing penetration of endovascular techniques and increasing uptake of premium-priced products, such as drug-eluting technologies and IVL, as well as a particular focus on procedures treating iliac and lower-limb arteries. Nevertheless, price competition, unfavorable reimbursement, and unwillingness by some clinicians to adopt new technologies will limit revenue growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Latin America from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – United States
Long-term growth of the US trauma device market will be driven by the uptake of novel technologies such as 3-D printed implants, the expansion of the foot and ankle device segment, site-of-service…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…
Report
Interventional Cardiology Devices – Market Insights – United States
The US interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Japan
The Japanese EP mapping and ablation device market will experience moderate growth through 2034, supported by rising cardiac arrhythmia prevalence, broader treatment accessibility, and ongoing…